COGT: Cogent Biosciences, Inc. Stock

by  •  • Comments Off on COGT: Cogent Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 631.84
Enterprise Value ($M) 644.28
Book Value ($M) 256.29
Book Value / Share 2.32
Price / Book 2.47
NCAV ($M) 224.86
NCAV / Share 2.04
Price / NCAV 2.81

Profitability (mra)
Return on Invested Capital (ROIC) -0.93
Return on Assets (ROA) -0.54
Return on Equity (ROE) -0.61

Liquidity (mrq)
Quick Ratio 5.32
Current Ratio 5.32

Balance Sheet (mrq) ($M)
Current Assets 296.47
Assets 327.90
Liabilities 71.61
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -275.94
Net Income -255.86
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -207.79
Cash from Investing 38.28
Cash from Financing 214.45

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Point72 Asset Management, L.P. 8.70 -33.94
02-12 13G Paradigm Biocapital Advisors LP 5.00
02-12 13G/A Fmr Llc 15.00 25.44
11-14 13G/A Venrock Healthcare Capital Partners II, L.P. 9.99 27.41
11-14 13G/A Commodore Capital Lp 9.30 70.09
11-14 13G/A Kynam Capital Management, LP 8.36 57.82
11-14 13G/A Suvretta Capital Management, Llc 0.00 -100.00
06-13 13D/A Fairmount Funds Management LLC 9.90 13.45

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 146,845 951,909 15.43
2025-04-02 227,314 1,452,125 15.65
2025-04-01 267,833 1,514,557 17.68
2025-03-31 159,437 1,743,186 9.15

(click for more detail)

Similar Companies
CGC – Canopy Growth Corporation CGEM – Cullinan Therapeutics, Inc.
CGON – CG Oncology, Inc. COLL – Collegium Pharmaceutical, Inc.
CPIX – Cumberland Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io